Draft Genetically Modified Organisms (Deliberate Release) (Amendment) (England) Regulations 2022 Debate
Full Debate: Read Full DebateGraham Stuart
Main Page: Graham Stuart (Conservative - Beverley and Holderness)Department Debates - View all Graham Stuart's debates with the Department for Environment, Food and Rural Affairs
(2 years, 5 months ago)
General CommitteesIt is a pleasure to serve with you in the Chair, Sir Gary, and I am grateful to the Minister, not just for her helpful introductory remarks but for the pre-meeting discussion we had a few days ago. She has set out clearly the Government’s view on this important piece of legislation. I will make Labour’s position very clear from the outset. We are not going to oppose this SI, but we are not satisfied that the Government have yet set out the clear and strong regulatory framework that is needed to provide the certainty that investors need, the reassurance that the public need, or the protection that the environment needs. All those things are important, but they are also interrelated, because investor confidence does not come without public confidence.
Labour is pro-science and pro-innovation. We want our scientists to succeed and use their skills for good here in the UK, and we know that crop development and innovation has brought us all huge gains. As Henry Dimbleby observed in the opening comments to the national food strategy—to which, of course, we still await a Government response—
“The food system we have today is both a miracle and a disaster”
providing
“enough calories (albeit unevenly distributed) to feed 7.8 billion of us…But the food we eat—and the way we produce it—is doing terrible damage to our planet and to our health.”
We agree, and it shows that we need to find ways to maintain and improve that efficiency, but also address the environmental and health damage that the modern food system has caused.
Some will say that more innovation just brings more problems, risks and dangers. We do not take that view, but we strongly believe that it is right to be careful, because this is about balancing risks, knowing that alongside the benefits—which absolutely should include significant environmental gains, such as reduced use of pesticides—there may be the danger that either mistakes are made, or there are things we simply do not know. That cannot paralyse us from action, because every intervention has risks attached, but we need a system that allows us to manage those trade-offs and those risks, and I am afraid that this SI does not do any of those things.
I am sure the Minister would say that it is not trying to do them: that this is a small step and, as she has indicated, that more will follow. That may be the case, and we agree that this is a relatively small step. It is important to be clear that this SI is about research, not products that reach consumers. However, I am afraid that the failure to provide the necessary structures and reassurances could turn a small step into a much bigger mistake if it fails to provide the necessary public reassurance.
It is fantastic to hear the hon. Member for Cambridge speaking enthusiastically in favour of one of the benefits of Brexit. Does he agree that the EU got this wrong and that, with the right provisions in place—I note that he is not opposing this SI—this is a journey to a better place, and one that the EU turned its face against?
I am grateful to have the opportunity to point out that this has nothing to do with Brexit, because of course the EU has embarked on much the same kind of path. It is already consulting on where it is likely to get to, and it is quite likely that we are going to get to a similar place at a similar time, as I will come on to later in my speech.
It is not just the Opposition who have concerns. The Lords Secondary Legislation Scrutiny Committee has made a series of strong criticisms that Ministers should take seriously, and that I hope Committee members have had the opportunity to consider. Committees in the other place often have comments about statutory instruments, but these are much more substantial than normal. The issue made it into the national print media, and on to national radio. When that level of public interest is generated by a report on the inner workings of this place, it should give the Government pause for thought. As the Secondary Legislation Scrutiny Committee says in its report, the regulations
“are politically or legally important and give rise to issues of public policy likely to be of interest to the House.”
I will briefly outline its concerns.
The Committee quotes the Government’s impact assessment, which makes interesting reading itself, and which I have looked at closely. The Committee cites the view widely held in the industry that the 2018 European Court of Justice judgment has held back research in the UK and the EU. The Committee says—this mirrors comments made elsewhere in the Government’s documentation—that
“the Government now intend to change the law…to allow GM plants that could have occurred naturally or through traditional breeding methods for release for non-marketing purposes. This is to enable the bioscience sector to test the benefits and safety of relevant new products ‘without the burden of unnecessary regulatory processes’.”
That is what this statutory instrument sets out to do, but the act of deregulation does not always lead to innovation; frankly, that is an ideological assertion. Page 1 of the impact assessment says that there is “some evidence” for the Government’s claim, but it does not say what that evidence is. The Minister may have it, and may be prepared to offer it, but others, myself included, would argue that in general it is good regulation, not a lack of regulation, that spurs innovation.
The Lords Secondary Legislation Scrutiny Committee says:
“Regrettably, the EM”—
the explanatory memorandum—
“does not provide any further information on the Government’s plans for wider reform.”
The Minister said in her opening comments, which I welcome, that primary legislation will be forthcoming, and I think she has confirmed that. Perhaps she can tell us a little more, because she mentioned that in our meeting earlier this week. The crucial question is what that primary legislation is designed to do—whether it will deregulate further, as I suspect it will, or whether it will set up, as I would much rather it did, a proper, fit-for-purpose regulatory system. Perhaps she can clarify that.
I am sure that the Minister has read the submission from the Royal Society of Biology to the consultation run by the Department for Environment, Food and Rural Affairs. It is lengthy, substantial and raises a number of interesting suggestions—it is in my pile of papers. It includes ways in which short-term improvements could have been made under existing legislation. Will the Minister tell us whether those suggestions were considered? It also sets out ideas for a future regulatory framework. Again, I would be grateful if the Minister commented on those.
The Secondary Legislation Scrutiny Committee also highlighted points made strongly by organisations such as Beyond GM and GM Freeze about the introduction of the term, “qualifying higher plant”, which is introduced in the SI. The Organic Farmers & Growers group described it as a term it does not “recognise in any way”. This is clearly a thorny issue, as a number of the submissions to the consultation confirm—as far as we can find out, I should say. I do not think that the Government chose to publish the submissions; I am not sure why. Most of the ones I have were found by going back to the organisations that submitted them. Let me give some examples. The Roslin Institute says:
“it is exceptionally challenging to define which changes to the genome could have been produced by ‘traditional’ breeding.”
The Royal Society says:
“this question is problematic as there is a difference between what could be produced by traditional breeding in theory and in practice”.
The Royal Society of Biology says:
“No clear criteria can be described that would determine whether an organism produced by genome editing or other genetic technologies could have been produced by traditional breeding. This means no clarity can be achieved using this principle, and it is not appropriate as the basis of regulation.”
That is a strong statement from experts in the field. I will read out that last sentence again:
“it is not appropriate as the basis of regulation”,
but that is how the Government are proceeding.
DEFRA’s response when pressed by the Secondary Legislation Scrutiny Committee was that the Advisory Committee on Releases to the Environment
“is in the process of developing guidance”
that
“will be available shortly.”
What is “shortly”? The response from the Lords was:
“We regret that the guidance has not yet been published, especially as the Department would have been aware of the concerns which were raised during consultation. The House may wish to press the Minister for an explanation why the guidance has not been made available in time for it to be taken into account by Parliament in its consideration of these draft Regulations. We urge the Department to ensure that the guidance is published in good time before the new rules come into effect and that this guidance is communicated effectively, in order to provide clarity to researchers and those who have concerns about the new policy.”
Well, quite. The guidance should have been ready when the draft SI was laid. Why was it not, and when will it be?
ACRE might be struggling to do something that the Royal Society of Biology and others say is simply not possible. Given that much of this is about retaining public confidence, I took a look at ACRE, on whose advice so much of the draft SI depends. They are seven very eminent and experienced people, and I am sure they do an excellent job, but in the declaration of interests, six of the seven record very direct links with companies that might well benefit from the technology—no fewer than three of them quote Syngenta. I simply say to the Minister: if or when the public look at this, I suspect we know what they are likely to think. Is there sufficient balance and independence? Is she sure that the regulatory framework is right?
The Lords Secondary Legislation Scrutiny Committee’s next concern follows from that uncertainty about the definition of qualifying higher plants, in that GMO developers in effect self-declare whether their product is in that category. Question 5 in the Committee’s list of questions to DEFRA queries that. The answer is that the advice from ACRE is that the risk from genetic technologies is no greater than traditional breeding—well, frankly, they would say that, and that is the nub of the argument. Will the Minister explain why she believes the public will have confidence in that approach, given that there is no way of anyone knowing or being able to find out whether something is being developed with the technology unless those developers choose to declare it? Frankly, with this draft SI, it is just down to trust.
Organic farmers are particularly concerned, given that the new notification measures do not include location, scale or details of containment measures. The DEFRA answer puts the onus on researchers, again relying on trust, which is not enough to reassure organic growers who risk loss of certification. When asked about who would be liable if something went wrong, DEFRA’s answer is, in essence, that it does not believe that that will happen.
Once again, I find myself with the Lords Secondary Legislation Scrutiny Committee on this. Its sensible conclusion was that
“the Department should consider conducting and publishing an evaluation of…new rules and of any environmental or economic damage, to inform the wider reforms that the Government intend to take forward in this area.”
Will the Minister agree to do that, and if not, why not? I appreciate that she may not have an immediate answer to hand on all or many of my questions, but if she committed to writing to me, that would be helpful.
The Lords Secondary Legislation Scrutiny Committee also points out the devolution issues: the draft SI applies to England, as the Minister said, while the Scottish and Welsh Governments have expressed concerns and are not pursuing equivalent changes. That may not be an issue now but, given the discussion about the UK internal market rules—some of us will remember them from some months ago—it is worth noting that there may well be challenges ahead as different parts of the UK take different approaches.
Finally—you will be pleased to hear, Sir Gary—from the Lords Secondary Legislation Scrutiny Committee came the bigger constitutional question of whether this is the right way to proceed on an issue of considerable public interest. The Committee makes a strong case that this should have been done through primary rather than secondary legislation, not least because there is no opportunity for amendment. Within this SI alone, it is clear that there are provisions ripe for amendment and debate, which cannot be done in Committee today.
Let me conclude by returning to the wider argument. The Government’s case, as I understand it, is that the existing safeguards mean that GE research is going elsewhere, not just from the UK but from the EU. As I said, the EU takes the same view and is consulting on similar changes. I suspect it will get to a similar place, but possibly—this is a risk for us—with a better overall regulatory structure. We need to be mindful of that.
If the aim is to allow small and medium-sized enterprises and start-ups to compete against much better-funded bigger players—and that is to be welcomed—they would be making a judgment about which regulatory regime will give them the best future. The Royal Society of Biology makes that point in its submission. That is why we need the right regulation; not only is no or limited regulation dangerous in itself, but it will not be attractive to those who want to take their research further, with regulatory approval from a much larger entity that serves a much bigger market. We want to know if and when that broader regulatory architecture will be available. When is the primary legislation going to be laid? How advanced is the thinking on it? What does the Minister have in mind? These are all reasonable questions that should have been answered before, not after, this initial step.
Will the Minister commit to ensuring that the guidance to be published clearly lays out how the current architecture works and explains precisely who does what and what the roles of ACRE, the Genetic Modification Inspectorate—which is, as the Minister said, a part of the Animal and Plant Health Agency—and the Food Standards Agency are? It is not obvious to many people how those fit together so it would be helpful to have it clearly laid out.
This relatively short SI raises many complicated, important and substantial questions, which will no doubt be returned to when we have primary legislation. As I said at the outset, Labour wants this technology to work. We want our scientists to be at the forefront, but that will happen only if everyone has confidence in the regulatory framework in which they operate. That is the way to get ahead—for consumers, producers and the environment. Get the framework right and we are on to a winner.
Is it not so important that, first, we get this right—the hon. Member for Cambridge was right to highlight questions in that respect—and secondly, that we send a signal to the industry, which is going to be so important in tackling the issues my hon. Friend has raised on the future of humanity, that the UK is open for business, is going to be led by science and will have a regulatory regime that is friendly to business and will allow us to be a major centre for tackling some of the biggest threats facing mankind?
I thank my hon. Friend for the vast experience he brings as a former Trade Minister. Having recently been on a trip to the Dubai Expo, where I talked about some of our agri-innovation opportunities and we looked at how different societies around the world can beat some of the challenges of ensuring food security, I could not agree with him more.
I wish to reassure the hon. Member for Cambridge, who took some time to articulate how he was not satisfied with the framework in respect of both guidance and investors. The rest of the GMO framework remains unchanged and will do so until we consult in the future, as I set out.
Let me turn to the scientific criterion for the “higher plant” equivalent to plants that could have been produced by traditional breeding methods. The composition of genetic material in individual plants of the same species is subject to high levels of natural variation and selection, which plant breeders have exploited for centuries. Our understanding of plant genomes and the accompanying advances in technology have increased significantly since the previous legislation and enabled scientists to utilise variation more efficiently by making precise changes to the plant’s DNA. Such changes are equivalent to those that could have been achieved by traditional breeding methods. That is what we mean by the classification of a “higher plant” in the provision.